Antidiabetic agents like GLP-1 analogues or SGLT-2 inhibitors are promising alternatives to insulin as they have low risk for hypoglycemia, but the experience in GC-induced hyperglycemia is small, and again, outcome studies are lacking [41,42,43,44]. Here, INS is linked to Hypoglycemia.